The cost of immunotherapy for breast cancer in Thailand generally ranges from $15,000 / ฿510,000 to $25,000 / ฿850,000. Prices depend on the specific immunotherapy drug (such as pembrolizumab or atezolizumab), the number of treatment cycles, and the hospital’s reputation. In the United States, the average cost is $70,000 / ฿2,380,000 (per ASCO). This means immunotherapy for breast cancer in Thailand costs about 71% less than in the U.S.
Thai hospitals typically include the initial consultation, lab and imaging tests, the immunotherapy drug, infusion administration, and basic follow-up care in the price. In the U.S., drug costs, infusion fees, and monitoring are often billed separately. Always confirm with your chosen hospital which services and medications are covered in the total price.